Pharmafile Logo
Pharmafocus logo
Advanced Search
shire_image_4

Shire launches long-acting ADHD drug in UK

March 9, 2016
Sales and Marketing ADHD, Shire

Shire has launched its long-acting ADHD drug Intuniv (guanfacine) in the UK, for children and adolescents aged 6-17. The treatment …

News
pfizer_building

Pfizer enters $5 billion share buyback deal with Goldman Sachs

March 9, 2016
Business Services, Research and Development Pfizer, Share buyback, Stock, markets

US drug major Pfizer (NYSE: PFE) on Wednesday said it has entered into an accelerated share repurchase agreement with Goldman, …

News
abpi_reception_close_7

Pharma industry’s contribution to NHS medicines bill tops £1 billion

March 9, 2016
Manufacturing and Production, Medical Communications, Research and Development ABPI, PPRS, goodwill, pharma industry

The pharmaceutical industry has now contributed over £1 billion to the Department of Health towards the cost of new medicines …

News

Late-stage Pfizer drug study shows significant reduction in haemophilia B bleeding

March 9, 2016
Research and Development BeneFIX, Pfizer, haemophilia B

Pfizer on Wednesday said late-stage trials for its drug candidate to treat haemophilia B showed prophylactic use resulted in significant reduction …

News

TiGenix says additional data for stem cell product affirms safety profile

March 9, 2016
Research and Development Crohn’s disease, TiGenix, crohn's disease, drug trial

Belgian biotech firm TiGenix said the results of a 52-week follow-up study of its trial drug for a stem-cell condition …

News
karl_ludwig_kley

Merck chief executive Karl-Ludwig Kley to step down in April

March 9, 2016
Medical Communications, Research and Development Denreon, Karl-Ludwig Kley, Merck, karl ludwig kley

 It has been announced that Karl-Ludwig Kley, chief executive officer at Merck, will step down from his position at the …

Appointment
biotrial_facility_rennes

French clinical trial tragedy “astonishing and unprecedented”, says report

March 9, 2016
Medical Communications, Research and Development Bial, Biotrial, France, clinical trial, death, rennes, tragedy

A report into the clinical trial tragedy in France in January has called the event “astonishing and unprecedented” but did …

News
peptimimesis

Ipsen and PeptiMimesis announce oncology research partnership

March 9, 2016
Research and Development INSERM, PeptiMimesis, ipsen, peptides

Specialist pharma company Ipsen is partnering with French start-up PeptiMimesis to develop and market of novel therapeutic peptides in oncology. …

News
clinical_trial

Crown Bioscience expands portfolio with PreClinOmics acquisition

March 9, 2016
Manufacturing and Production, Research and Development cardiovascular, collaboration, crown bioscience, metabolic, preclinomics

Crown Bioscience has announced the acquisition of PreClinOmics, which will see the US-based drug discovery solutions company expand its cardiovascular …

News
merckincweb2

MSD joins charity-industry partnership Dementia Consortium

March 9, 2016
Medical Communications, Research and Development MSD, alzheimer's society, dementia, dementia consortium

The Dementia Consortium has welcomed MSD into the fold as a new partner in its global venture to accelerate drug …

News
medimmune_logo_on_building

AZ drug gets orphan status for rare inflammatory disease

March 9, 2016
Research and Development AstraZeneca, MEDI-551, MedImmune, orphan drug

AstraZeneca’s biologics R&D arm MedImmune has been granted Orphan Drug Designation by the FDA for its investigational anti-CD19 monoclonal antibody, …

News

Genmab ends ofatumumab trials for autoimmune conditions; to focus on multiple sclerosis

March 9, 2016
Research and Development Arzerra, GSK

Danish drug-company Genmab (Nasdaq Copenhagen: GEN) said it will discontinue the late-stage trials for Arzerra (ofatumumab) to develop a treatment for …

News

Medimmune gets US FDA fast track designation for flu drug

March 9, 2016
Research and Development

UK drug major AstraZeneca (LSE: ANZ) said its biologics R&D unit, MedImmune, has received Fast Track designation from the US …

News

Groundbreaking Ceremony of SHL Group New Site

March 9, 2016
Manufacturing and Production

  In Q1 2018, all administrative offices and parts of the production will be relocated to the new site. The ground …

News
Press release
bayercross3

Bayer to collaborate on new treatments for tuberculosis with Universities of Dundee, Cape Town

March 8, 2016
Manufacturing and Production, Research and Development Bayer, TB, tuberculosis, university of cape town, university of dundee

The pharmaceuticals division at German-based Bayer will collaborate with the renowned medicinal chemistry and biology departments at the Universities of …

News
amgen_sign_on_wall

Amgen open to larger M&A deals, says CFO

March 8, 2016
Sales and Marketing Amgen, mergers and acquisitions

Amgen’s chief financial officer has indicated that the company is ready to consider doing larger deals to buy other companies, …

News
sanofi_pasteur_msd

Sanofi Pasteur and MSD end European vaccines partnership

March 8, 2016
Medical Communications, Research and Development, Sales and Marketing MSD, Sanofi Pasteur, Sanofi pasteur msd, vaccines

Sanofi Pasteur and MSD have announced that they will end their joint vaccines operations in Europe, bringing an end to …

News
dr_virginia_jamieson_

Kuros Biosciences re-appoints chief medical officer

March 8, 2016
Medical Communications

Kuros Biosciences has announced the appointment of Dr Virginia Jamieson as chief medical officer and member of the executive board …

Appointment
microsoft_novartis_kinect

Novartis and Microsoft team up for Kinect collab

March 8, 2016
Manufacturing and Production, Research and Development Microsoft, Novartis, multiple sclerosis

Novartis has partnered with technology giant Microsoft; hoping to use its Kinect motion sensor to quantify whether its multiple sclerosis …

Feature

Merck posts 15% rise in Q4 profits driven by Sigma-Aldrich acquisition

March 8, 2016
Manufacturing and Production, Sales and Marketing

German drug maker Merck on Tuesday said it sees the acquisition of Sigma-Aldrich to aid sales in 2016 and reported …

News
The Gateway to Local Adoption Series

Latest content

SMC accepts amivantamab and lazertinib for EGFR-positive lung cancer

May 22, 2026

BioDuro and CTI Biotechnology in preclinical drug development partnership

May 21, 2026

Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology

May 21, 2026

NICE recommends sotatercept for pulmonary arterial hypertension

May 20, 2026

Vetter begins construction of new injectable medicines facility

May 20, 2026